Skip to content

Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery

Efficacy of Antibiotic Steroid Combination Compared With Individual Administration in Prevention of Post Operative Inflammation in Patients Having LASIK Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00330824
Enrollment
64
Registered
2006-05-29
Start date
2006-04-30
Completion date
2006-12-31
Last updated
2009-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Lasik Surgery Inflammation

Keywords

prevention of post inflammation in LASIK surgery

Brief summary

Efficacy/Safety of antibiotic steroid combination compared with individual administration in inflammation Post-LASIK

Detailed description

antibiotic/steroid combination compared to individuals components 15 days of treatment

Interventions

1gtt, 4x/d, 15 days

DRUGmoxifloxacin/dexamethasone

1gtt, 4x/days, 15 days

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* patients having LASIK surgery; * men or women of any race, between 18 and 50 years old, presenting up to 8 degrees of myopia or up to 4 degrees of hypermetropia, or up to 3 degrees of astigmatism, without any other associated ocular problems

Exclusion criteria

* Uncontrolled glaucoma or intraocular hypertension; * Use of any ocular anti-infectious drugs or any topical or systemic ocular NSAIDs during the study but study drugs; * A history of chronic or recurrent ocular inflammatory disease; * Uncontrolled diabetes mellitus and diabetic retinopathy ; * Patients with sight in a single eye; * Iris atrophy in the eye to be operated; * Pregnant or lactating women, or women of childbearing potential who are not using proper birth-control methods; * Known or suspected allergy or hypersensitivity to any component of study medication; * A history or any other evidence of severe systemic disease

Design outcomes

Primary

MeasureTime frame
day 15 evaluation of anterior chamber15 days pos-op

Secondary

MeasureTime frame
day 15 evaluation of ocular pain, physician´s follow-up impression of inflammatory reaction score15 days pos-op

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026